Literature DB >> 23930060

Fatty liver disease in an autopsy series of children and adolescents.

F Yüksel1, D Türkkan, I Yüksel, S Kara, N Celik, Et Samdancı.   

Abstract

BACKGROUND AND AIMS: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children and adolescents. Obesity is a major risk factor for NAFLD; however, it has been shown that NAFLD is not rare in non-obese adults. The aim of this study was to determine the prevalence of NAFLD in obese and non-obese children and adolescents.
METHODS: The medical records of 340 subjects (aged 2-20 years) in whom autopsy was performed were retrospectively reviewed. Of those, 10 subjects were excluded due to insufficient data. The remaining 330 subjects were included in the study, of whom 264 were normal weight and 66 were obese. All liver biopsy sections were evaluated by two pathologists in a blinded fashion.
RESULTS: The prevalence of fatty liver was 6% among all the subjects and was higher in the overweight group than in the normal-weight group (10.6% vs 4.9%; p<0.001). The prevalence of NAFLD increased concomitant with age. There was no significant difference between sexes in cases with NAFLD. Simple steatosis was detected in 7 subjects. Steatohepatitis was determined as type 1 in 5 subjects, type 2 in 7 subjects, and as overlap in 1 subject.
CONCLUSIONS: This study demonstrated that NAFLD is an important public health problem not only in obese but also in non-obese children and adolescents. This suggests that whereas obesity may be a risk factor, other pathogenic factors may exist that could contribute to the NAFLD.

Entities:  

Keywords:  adolescents; autopsy; children; fatty liver disease; obesity

Year:  2012        PMID: 23930060      PMCID: PMC3738396     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  24 in total

1.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Authors:  Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

2.  Paediatric non-alcoholic fatty liver disease.

Authors:  Valerio Nobili; Massimo Pinzani
Journal:  Gut       Date:  2010-05       Impact factor: 23.059

3.  Controversies in the management of pediatric liver disease: Hepatitis B, C and NAFLD: Summary of a single topic conference.

Authors:  Benjamin L Shneider; Regino González-Peralta; Eve A Roberts
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

Review 4.  Nonalcoholic steatohepatitis: definition and pathology.

Authors:  E M Brunt
Journal:  Semin Liver Dis       Date:  2001       Impact factor: 6.115

5.  Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents.

Authors:  Hye Soon Park; Jee Hye Han; Kyung Mook Choi; Seon Mee Kim
Journal:  Am J Clin Nutr       Date:  2005-11       Impact factor: 7.045

6.  Serum alanine aminotransferase activity in obese children.

Authors:  Y Tazawa; H Noguchi; F Nishinomiya; G Takada
Journal:  Acta Paediatr       Date:  1997-03       Impact factor: 2.299

7.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

Review 8.  Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.

Authors:  Janardan K Reddy; M Sambasiva Rao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-05       Impact factor: 4.052

Review 9.  Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.

Authors:  N J Barshop; C B Sirlin; J B Schwimmer; J E Lavine
Journal:  Aliment Pharmacol Ther       Date:  2008-04-04       Impact factor: 8.171

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  5 in total

Review 1.  Non-alcoholic fatty liver disease: A growing public health problem in Turkey.

Authors:  Eda Kaya; Yusuf Yılmaz
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

Review 2.  Advancing the global public health agenda for NAFLD: a consensus statement.

Authors:  Jeffrey V Lazarus; Henry E Mark; Quentin M Anstee; Juan Pablo Arab; Rachel L Batterham; Laurent Castera; Helena Cortez-Pinto; Javier Crespo; Kenneth Cusi; M Ashworth Dirac; Sven Francque; Jacob George; Hannes Hagström; Terry T-K Huang; Mona H Ismail; Achim Kautz; Shiv Kumar Sarin; Rohit Loomba; Veronica Miller; Philip N Newsome; Michael Ninburg; Ponsiano Ocama; Vlad Ratziu; Mary Rinella; Diana Romero; Manuel Romero-Gómez; Jörn M Schattenberg; Emmanuel A Tsochatzis; Luca Valenti; Vincent Wai-Sun Wong; Yusuf Yilmaz; Zobair M Younossi; Shira Zelber-Sagi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-10-27       Impact factor: 46.802

Review 3.  Caring for children with NAFLD and navigating their care into adulthood.

Authors:  Ali A Mencin; Rohit Loomba; Joel E Lavine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

4.  The prevalence of non-alcoholic fatty liver disease in healthy young persons.

Authors:  Gokcan Okur; Zehra Karacaer
Journal:  North Clin Istanb       Date:  2016-11-16

5.  Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children.

Authors:  Peige Song; Jinyue Yu; Manli Wang; Xinlei Chang; Jiawen Wang; Lin An
Journal:  Int J Environ Res Public Health       Date:  2017-04-27       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.